
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27389025</article-id><article-id pub-id-type="pmc">4937552</article-id><article-id pub-id-type="publisher-id">1336</article-id><article-id pub-id-type="doi">10.1186/s13054-016-1336-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letter</subject></subj-group></article-categories><title-group><article-title>Using noninvasive ventilation to prevent extubation failure: it is good news, but do we really know what &#x0201c;high risk&#x0201d; means?</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Glossop</surname><given-names>Alastair J.</given-names></name><address><email>alastair.glossop@sth.nhs.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Esquinas</surname><given-names>Antonio M.</given-names></name><address><email>antmesquinas@gmail.com</email></address><xref ref-type="aff" rid="Aff2"/></contrib><aff id="Aff1"><label/>Department of Critical Care, Sheffield Teaching Hospitals NHS Foundation Trust, Herries Road, Sheffield, S5 7AU UK </aff><aff id="Aff2"><label/>Intensive Care and Non Invasive Ventilatory Unit, Hospital Morales Meseguer, Avenida Marques de Los Velez, Murcia, 30.008 Spain </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>7</month><year>2016</year></pub-date><pub-date pub-type="ppub"><year>2016</year></pub-date><volume>20</volume><elocation-id>213</elocation-id><history><date date-type="received"><day>29</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2016</copyright-statement><license license-type="OpenAccess"><license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2016</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p>We read with great interest the article by Thille et al. [<xref ref-type="bibr" rid="CR1">1</xref>] and commend the authors on their work. It is accepted that noninvasive ventilation (NIV) used prophylactically reduces post-extubation respiratory failure, but its impact on reintubation remains contentious [<xref ref-type="bibr" rid="CR2">2</xref>]. Therefore, the current study, which reports reduced rates of reintubation from 28&#x000a0;% to 15&#x000a0;% in high-risk populations with NIV use, is welcomed.</p><p>The study has several limiting factors. It is a prospective before&#x02013;after study across a long time period, and the authors acknowledge this potential source of bias. There is a large gap between patient cohorts, with data from the original cohort collected between 2005 and 2006 and data from the &#x0201c;after&#x0201d; group collected between 2010 and 2012. No explanation is provided as to why this second period&#x02014;4&#x000a0;years later&#x02014;was chosen, which raises concerns regarding selection bias. Additionally, data were collected from a single centre with extensive experience of NIV use, an important factor in the success of NIV use post-extubation [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p>In mitigation, no difference between baseline reintubation rates of low-risk patients was seen between the two groups, and the second patient cohort contained fewer surgical patients&#x02014;a group known to benefit from post-extubation NIV use [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p>We applaud the definition of extubation failure as reintubation within 7&#x000a0;days rather than 48&#x02013;72&#x000a0;h, as we feel this provides a pragmatic view. It is likely to result in greater numbers of extubation failures and makes the findings more impressive. We also feel that an average time of NIV use of 8&#x000a0;h within the first 24&#x000a0;h represents a reproducible period for prophylactic use in critical care patients, in whom treatment compliance may be an issue.</p><p>We feel that this is an important study and welcome its contribution to the evidence pool. It does, however, raise the important question of what constitutes &#x0201c;high risk&#x0201d; of extubation failure. The authors state that NIV is &#x0201c;pointless&#x0201d; as a prophylactic measure in low-risk populations, but define over 60&#x000a0;% of patients included as high risk; as demands on frontline services increase this figure is surely set to rise. The emergence of high-flow nasal cannula (HFNC) therapy in patients defined as low risk of extubation failure [<xref ref-type="bibr" rid="CR5">5</xref>] brings an even sharper focus on the need for risk stratification in all ICU patients, and further work is warranted to help guide post-extubation management.</p><sec id="Sec1"><title>Abbreviations</title><p>HFNC, high-flow nasal cannula; ICU, intensive care unit; NIV, noninvasive ventilation.</p></sec></body><back><fn-group><fn><p>See related research by Thille et al., <ext-link ext-link-type="uri" xlink:href="http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1228-2">http://ccforum.biomedcentral.com/articles/10.1186/s13054-016-1228-2</ext-link>
</p></fn></fn-group><ack><sec id="FPar1"><title>Authors&#x02019; contributions</title><p>AJG and AME constructed, read, and approved the final manuscript.</p></sec><sec id="FPar2"><title>Competing interests</title><p>AJG has received honoraria and speaking fees from Armstrong Medical UK between 2014 and 2016.</p></sec></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thille</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Easily identified at-risk patients for extubation failure may benefit from noninvasive ventilation: a prospective before-after study</article-title><source>Crit Care</source><year>2016</year><volume>20</volume><issue>1</issue><fpage>48</fpage><pub-id pub-id-type="doi">10.1186/s13054-016-1228-2</pub-id><pub-id pub-id-type="pmid">26926168</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial</article-title><source>Lancet</source><year>2009</year><volume>374</volume><issue>9695</issue><fpage>1082</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(09)61038-2</pub-id><pub-id pub-id-type="pmid">19682735</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrer</surname><given-names>M</given-names></name><etal/></person-group><article-title>Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>168</volume><issue>12</issue><fpage>1438</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1164/rccm.200301-072OC</pub-id><pub-id pub-id-type="pmid">14500259</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glossop</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Non-invasive ventilation for weaning, avoiding reintubation after extubation and in the postoperative period: a meta-analysis</article-title><source>Br J Anaesth</source><year>2012</year><volume>109</volume><issue>3</issue><fpage>305</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1093/bja/aes270</pub-id><pub-id pub-id-type="pmid">22879654</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maggiore</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Nasal high-flow versus Venturi mask oxygen therapy after extubation. Effects on oxygenation, comfort, and clinical outcome</article-title><source>Am J Respir Crit Care Med</source><year>2014</year><volume>190</volume><issue>3</issue><fpage>282</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1164/rccm.201402-0364OC</pub-id><pub-id pub-id-type="pmid">25003980</pub-id></element-citation></ref></ref-list></back></article>